Vetr Upgrades Intuitive Surgical (ISRG) to Buy

Intuitive Surgical (NASDAQ:ISRG) was upgraded by stock analysts at Vetr from a “hold” rating to a “buy” rating in a research note issued to investors on Monday. The firm presently has a $434.75 price objective on the medical equipment provider’s stock. Vetr‘s price objective indicates a potential upside of 10.95% from the company’s previous close.

A number of other research firms also recently issued reports on ISRG. Goldman Sachs Group reiterated a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 price objective on the stock in a report on Tuesday, November 14th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday. Evercore ISI started coverage on shares of Intuitive Surgical in a research note on Wednesday, January 3rd. They issued an “in-line” rating and a $380.00 target price for the company. Finally, BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $346.16.

Intuitive Surgical (NASDAQ:ISRG) traded up $12.85 during midday trading on Monday, hitting $391.86. 963,800 shares of the stock were exchanged, compared to its average volume of 941,513. Intuitive Surgical has a 12 month low of $211.33 and a 12 month high of $405.05. The firm has a market capitalization of $43,910.00, a P/E ratio of 50.63, a PEG ratio of 5.33 and a beta of 0.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The company had revenue of $806.10 million for the quarter, compared to the consensus estimate of $753.25 million. During the same period last year, the company earned $2.06 earnings per share. The firm’s revenue was up 18.0% compared to the same quarter last year. analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current year.

In related news, SVP Curet Myriam sold 262 shares of the firm’s stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $373.00, for a total value of $97,726.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark J. Meltzer sold 3,000 shares of Intuitive Surgical stock in a transaction on Monday, November 27th. The stock was sold at an average price of $400.00, for a total transaction of $1,200,000.00. Following the transaction, the senior vice president now directly owns 9,888 shares of the company’s stock, valued at $3,955,200. The disclosure for this sale can be found here. Insiders sold 55,944 shares of company stock valued at $21,432,971 over the last three months. 2.20% of the stock is owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in ISRG. Neuberger Berman Group LLC boosted its position in Intuitive Surgical by 112.1% during the second quarter. Neuberger Berman Group LLC now owns 1,336 shares of the medical equipment provider’s stock worth $1,250,000 after purchasing an additional 706 shares during the period. Schroder Investment Management Group bought a new position in Intuitive Surgical during the second quarter worth $14,441,000. Commonwealth Bank of Australia boosted its position in Intuitive Surgical by 614.0% during the second quarter. Commonwealth Bank of Australia now owns 921 shares of the medical equipment provider’s stock worth $860,000 after purchasing an additional 792 shares during the period. Martingale Asset Management L P boosted its position in Intuitive Surgical by 22.0% during the second quarter. Martingale Asset Management L P now owns 1,663 shares of the medical equipment provider’s stock worth $1,556,000 after purchasing an additional 300 shares during the period. Finally, SVA Plumb Wealth Management LLC boosted its position in Intuitive Surgical by 1.6% during the second quarter. SVA Plumb Wealth Management LLC now owns 6,224 shares of the medical equipment provider’s stock worth $5,822,000 after purchasing an additional 96 shares during the period. 32.80% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Vetr Upgrades Intuitive Surgical (ISRG) to Buy” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/08/vetr-upgrades-intuitive-surgical-isrg-to-buy.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

To view Vetr’s full report, visit Vetr’s official website.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

What are top analysts saying about Intuitive Surgical? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intuitive Surgical and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit